Artboard 1

hsDNA

The latest from HSD

Upcoming Events

See All

Recent News & Events

See All

HS Design, Inc. Awarded Phase II Contract from the National Institutes of Health

Gladstone, NJ, September 15, 2019  HS Design, Inc. has been awarded a National Institutes of Health (NIH) National Cancer Institute Small Business Innovation Research (SBIR) Phase II contract under award number 75N91019C00039. This Phase II contract supports the research and development efforts of HS Design for developing Sympfiny® a novel dosing and dispensing system for multi-particulate cancer […]
More info

HSD Awarded Silver IDEA

HS Design is very proud to have won a Silver award in the Social Impact category for Sympfiny® at this year’s IDSA International Design Excellence Awards (IDEA). HSD created Sympfiny® out of a competition for the dosing of oral delivery of multi-particulate, dry powder and microsphere drug formulations for low-resource settings. Michael Quinn and Brian Pughe […]
More info